Skip to main content
. 2018 Jan 18;9(10):9299–9310. doi: 10.18632/oncotarget.24271

Table 1. Patients characteristics.

Characteristics No. of patients (%)
N 71
Age (years) Mean ± SD 53.7 ± 13.7
≤45 22 (31.0)
46–55 18 (25.4)
56–65 15 (21.1)
≥ 66 16 (22.5)
PS 0 13 (18.3)
1 41 (57.7)
2 14 (19.7)
3 3 (4.2)
Follow-up time (months) Median 19.9
Mean ± SD 34.2 ± 38.4
Range 1.9 - 177.4
Tumor characteristics Maximum tumor diameter (mm): mean ± SD 67.0 ± 21.4
Tumor volume (cc) 112.71 ± 97.47
Invasion of bladder Histologically proven 15 (21.1)
Cystoscopy 13 (18.3)
Laparoscopy 1 (1.4)
MRI 39 (54.9)
CT scan 3 (4.2)
Invasion of rectum 13 (18.3)
Fistula at diagnosis Bladder 8 (11.3)
Rectum 1 (1.4)
Parametrial invasion Unilateral 8 (11.3)
Bilateral 61 (85.9)
No 2 (2.8)
Clinical distal parametrial involvement 45 (63.4)
Vaginal invasion Yes 55 (77.5)
Limited to the upper two-third 36 (50.7)
Lower third involvement 19 (26.8)
Hydronephrosis Unilateral 37 (52.1)
Bilateral 20 (28.2)
No 14 (19.7)
Stage (FIGO) IV A 48 (67.6)
IV B 23 (32.4)
Nodal involvement No 24 (33.8)
Pelvic nodes only 26 (36.6)
Para-aortic nodes only 5 (7.0)
Both pelvic and para-aortic 16 (22.5)
PALN involvement CT scan 3 (4.2)
MRI 9 (12.7)
PET 8 (11.3)
PALN dissection 1 (1.4)
Metastasis at diagnosis Ovarian 2 (2.8)
Peritoneal 1 (1.4)
Dorsal vertebra 1 (1.4)
Supraclavicular node 1 (1.4)
Para-aortic nodes laparoscopic staging Positive 1 (1.4)
Negative 11 (15.5)
Histology Squamous cell carcinoma 61 (85.9)
Adenocarcinoma 8 (11.3)
Other 2 (2.8)
Differentiation Low 21 (29.6)
Moderate 20 (28.2)
High 19 (26.8)
Unknown 11 (15.5)

Abbreviations: SD: standard deviation; FIGO: International Federation of Gynecology, Obstetrics; CT: computed Tomography; MRI: magnetic resonance imaging. PALN: para-aortic lymph nodes.